Phase 4
N=70
Intra-articular Morphine and Clonidine Injections for Pain Management in Hip Arthroscopy
Femoracetabular Impingement · Pain, Postoperative
Bottom Line
View on ClinicalTrials.gov: NCT02530151 ↗Enrolled (actual)
70
Serious AEs
—
Results posted
May 2019
Primary outcome: Primary: Opioid Consumption in the Acute Postoperative Period — 57.3; 56.0; 37.0; 40.1 milligram morphine equivalents (mEq)
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- Morphine with clonidine (Drug); Normal saline (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Northwestern University
- Primary completion
- May 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Opioid Consumption in the Acute Postoperative Period |
57.3; 56.0; 37.0; 40.1; 5.5; 5.3 | — |
| SECONDARY Visual Analog Scale (VAS) Pain Scores |
2; 2; 3; 4; 4; 5 | — |
| SECONDARY Quality of Recovery (QoR-15) Scores for Patient Reported Recovery Following Surgery |
123; 131; -22; -20 | — |
Summary
The purpose of this study is to determine whether intraoperative (during surgery) morphine and clonidine hip injections are effective in postoperative pain management for patients undergoing hip arthroscopy.
Eligibility Criteria
Inclusion Criteria
- Any patient undergoing a hip arthroscopy procedure for femoracetabular impingement by the senior surgeon (M.T.)
Exclusion Criteria
- Morphine contraindication
- Clonidine contraindication
- Pregnant women
- Prisoners
- Adults unable to consent
Data sourced from ClinicalTrials.gov (NCT02530151). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.